Interim 18F-FGD PET/CT may not predict the outcome in primary central nervous system lymphoma patients treated with sequential treatment with methotrexate and cytarabine
Crossref DOI link: https://doi.org/10.1007/s00277-017-3068-9
Published Online: 2017-07-19
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jo, Jae-Cheol
Yoon, Dok Hyun
Kim, Shin
Lee, Kyoungmin
Kang, Eun Hee
Park, Jung Sun
Ryu, Jin-Sook
Huh, Jooryung
Park, Chan-Sik
Kim, Jong Hoon
Lee, Sang Wook
Suh, Cheolwon
License valid from 2017-07-19